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Circadian rhythm and profile in patients with
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ABSTRACT
Objective: This study intended to compare the circadian rhythm and circadian profile between patients with juvenile myoclonic epilepsy
(JME) and patients with temporal lobe epilepsy (TLE). Method: We enrolled 16 patients with JME and 37 patients with TLE from the
Outpatient Clinic of UNICAMP. We applied a questionnaire about sleep-wake cycle and circadian profile. Results: Fourteen (87%) out of 16
patients with JME, and 22 out of 37 (59%) patients with TLE reported that they would sleep after seizure (p , 0.05). Three (19%) patients
with JME, and 17 (46%) reported to be in better state before 10:00 AM (p , 0.05). Conclusion: There is no clear distinct profile and
circadian pattern in patients with JME in comparison to TLE patients. However, our data suggest that most JME patients do not feel in
better shape early in the day.
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RESUMO
Objetivo: Este estudo pretende comparar o ritmo circadiano e o perfil circadiano entre pacientes com epilepsia mioclônica juvenil (EMJ) e
epilepsia de lobo temporal (ELT). Método: Nós entrevistamos 16 pacientes com EMJ e 37 com ELT do ambulatório da UNICAMP. Nós
aplicamos um questionário sobre ciclo sono-vigília e perfil circadiano. Resultados: Quatorze (87%) de 16 pacientes com EMJ e 22 de 37
(59%) pacientes com ELT relataram que eles apresentam sonolência pós-crise (p , 0,05). Três (19%) pacientes com EMJ e 17 (46%)
relataram um melhor estado geral antes das 10h00min (p , 0,05). Conclusão: Não há uma clara diferença de ritmo e de perfil circadiano
entre pacientes com EMJ e ELT. No entanto, nossos dados sugerem que a maioria dos pacientes com EMJ não se sentem em sua melhor
forma cedo pela manhã.
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Epilepsy is a chronic neurological disease, comprising dif-
ferent group of causes that have in common seizures that
recur in the absence of toxic-metabolic disease or fever.
The classification of epilepsies or epileptic syndromes pro-
posed by ILAE1 attempts to group epilepsy in different sub-
sets based on similarities in seizure type, age of onset,
clinical and neurological signs, family history, findings of
complementary tests (EEG, imaging) and prognosis.
Juvenile myoclonic epilepsy (JME), focus of this study, is one
type of the generalized idiopathic epileptic syndrome. JME has
clinical presentation between 12 and 18 years old, with short
and sudden muscle contractions called myoclonic seizures.
These manifestations may be associated with tonic-clonic
and also absence seizures2. The treatment of JME is based on
the administration of antiepileptic drugs (AEDs) and control-
ling precipitating factors (sleep deprivation, emotional stress
and alcohol use)3,4,5,6,7. Although, patients can have seizure con-
trolled with medication, the recurrence rate is high, thus there
is a need to continue their medications without interruption3.
One important factor of worsening in seizure frequency
of JME is related to lack of sleep, so as to suggest that there
is a causal relationship between these two factors8. There is
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also evidence that sleep deprivation causes seizures in
patients with epilepsy, and sleep apnea can intensify these
seizures. In addition, NREM (synchronized nonrapid eye
movement) sleep stage facilitates the occurrence of seizures,
while another stage of sleep known as REM (desynchronized
rapid eye movement) hinders their occurrence8.
Pung and Schmitz9 studied a group of 20 patients with
JME and described their patients with alterations in the cir-
cadian rhythm, whereas the patients were considered of
“evening types”9. Thus, if we assume that there is a specific
profile that characterizes patients with JME in relation to the
circadian rhythm, this has significance in directing the clin-
ical treatment of patients, given the evidence of close rela-
tionship between sleep and epilepsy. However, one could
argue that other factors may be in place, as social-cultural
background of patients instead of neurobiological factors
related to JME. Therefore, our objective is to compare the
circadian rhythm and circadian profile between patients
with JME and temporal lobe epilepsy (TLE).
METHOD
We invited in this study adult patients (not less than 18
years) with diagnosis of JME and TLE undergoing treatment
at the Ambulatório de Epilepsia do Hospital de Clínica da
Universidade Estadual de Campinas from 14/June/2010 to
30/May/2011. Patients with co-morbidities, especially psy-
chiatric, were excluded.
We used the questionnaire for identifying the character-
istics of sleep-wake cycle and circadian profile based on an
existing questionnaire1 by Pung and Schimit. We translated
and adapted the questionnaire for Brazilian Portuguese.
This questionnaire is composed by six topics which asks
about the patient’s preferences about doing a task before
or after 10:00 AM, about being a nocturnal or diurnal person,
about the physical state at the morning and about how
awake he or she feels after waking.
In addition, we collected the demographic data about the
patients during the interview and complemented with
information from patient’s file whenever needed.
On the concepts of the analysis, we defined seizure-free
as a period of twelve months without seizures. We also
defined the sedative antiepileptic drugs, which could affect
the sleepiness of the patient as the following drugs: cloba-
zam, clonazepam and phenobarbital.
Ethics
The Research ethics committee (CEP) of Faculdade de
Ciências Médicas of Universidade Federal de Campinas, meeting
all the provisions of the resolutions no. 196/96 and comple-
mentary, approved without restrictions on May 13, 2010, the
research protocol, as well as the Consent term and all other
attachments included in the survey. The document proving
this approval is the opinion of the CEP no. 169/2010.
The participation of the research subjects is voluntary and
participants are aware of the whole process. They have signed
terms of informed consent, in which it is informed that the data
are collected under guard of scientific and professional secrecy.
RESULTS
We enrolled 53 patients in this study. Sixteen (30%) had
JME, mean age 32 (range 21 to 53), with four men (25%). The
mean age of onset was 12 (range from 2 to 21). Eight
patients (50%) were on monotherapy (valproic acid = 5;
lamotrigine = 2; topiramate = 1).
Thirty-seven had TLE (70%), mean age 47 (range 23 to
66), with 14 men (38%). The mean age of onset was 16 (range
from 1 to 62). Sixteen patients (43%) were on monotherapy
(Carbamazepine = 12; Phenobarbital = 1; topiramate = 1,
lamotrigine = 1; clonazepam = 1).
We used Chi-square to assess statistical difference,
assuming the corrected p-value , 0.05 as significant. We
opted for individual assessment, knowing the caveat of such
approach, but having in mind as a way for an exploratory
view of the data. The circadian rhythm is shown in Table
1 and the circadian profile is shown in Table 2.
The statistical significant differences were: TLE patients
tend to be in better state before 10:00 AM and JME patients
use to sleep after seizure.
There are 5 (31%) patients with JME that are in use of
sedative antiepileptic drugs, in contrast to 16 (44%) patients
with TLE that are in use of these type of with medication
(Chi-square50.80, p50.16). These numbers show that there
Table 1. Circardian rhythm of patients with JME and TLE.
JME (n = 16) TLE (n = 37) Chi-square p-value
Sleep easily 13 (81%) 26 (70%) 0.69 0.19
With sleep disruptions 7 (44%) 25 (68%) 2.64 0.06
Seizures during sleep 7 (44%) 19 (51%) 0.25 0.20
With sleep symptoms 2 (13%) 7 (19%) 0.32 0.27
Reported waking up tired 6 (38%) 11 (30%) 0.30 0.21
Use to sleep after seizure 14 (88%) 22 (59%) 4.03 0.03
JME: Juvenile myoclonic epilepsy; TLE: Temporal lobe epilepsy.
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is no significant difference between these 2 groups for the
information about number of sedative antiepileptic drugs
in use.
Considering that seizure-free is defined by a period of 12
months without seizures, five (33%) patients with JME are
not-seizure-free, in contrast to 24 (65%) patients with TLE
who are not-seizure-free (Chi-square54.30, p50.03). These
numbers show that there is significant difference between
these 2 groups for the information about seizure-free period.
DISCUSSION
The circadian rhythm between the JME and the TLE
patients shows similar pattern between both groups. The
only tendency was the fact that patients with JME appear
to sleep more after the seizure. This is possibly explained
by the seizure type, as mostly, patients with JME had
tonic-clonic seizure compared to TLE that has complex par-
tial seizure.
In circadian profile, TLE patients tend to be in better
state before 10:00 AM when compared to the JME patients.
Comparing these data to data from Pung and Schimtz9, in
both of the studies, we found the same information that
the TLE patients tend to feel in better state before 10:00 AM.
On the other hand, in our study there is no definition
about the patients on being “evening types” or “morning
types”, in contrast to the results from the Germany study,
in which the JME patients were defined as “evening types”9
and the TLE patients as “morning types”. This can be in part
due to the sociocultural differences between the countries
from where the patients were taken.
Previous studies report that pattern of seizure occur-
rence in JME patients tend to be on awakening (diurnal
seizures)10,11,12,13,14, while TLE patients tend to have seizures
during sleep (nocturnal seizures)11,12. These studies argue
against our finding that TLE patients tend to feel in better
state before 10:00 AM, who should be more sleepy at the
morning if they have had the sleep interruptions secondary
to seizures during sleep. Therefore, the controversial data
shows that the seizure factor does not contribute to sleepi-
ness on morning on the TLE patients of our study.
According to the property of the anticonvulsant drugs to
improve sleep by decreasing seizures but to cause sleep dis-
ruptions by mechanisms of independent neuromodula-
tion15,16,17,18,19,20,21, it is important to discuss the therapy in
use by the patients. For example, the excessive daytime
sleepiness were reported to be associated to low seizures
control and to monotherapy with low antiepileptic drugs
serum levels21. There is also a link between the number of
antiepileptic drugs in use and the increase of the seizure’s
frequency with the excessive daytime sleepiness22,23,24. The
type of the antiepileptic drug is also an important factor.
For example, there are a few ones that promote stabilization
and normalization of the sleep, such as phenytoin25,26, carba-
mazepine20,25,27, phenobarbital25 and benzodiazepines28,29.
However, there are some sedative antiepileptic drugs that
may increase the sleepiness, such as clobazam, clonazepam
and phenobarbital, which we defined as sedative AEDs.
There is no difference between the JME and the TLE patients
about the information of the number of sedative AEDs in use.
Therefore, this information is not significant to this study.
CONCLUSION
In conclusion, there is no clear distinct profile and cir-
cadian pattern in patients with JME in comparison to TLE
patients. However, our data suggest that most JME patients
do not feel in better shape early in the day. It is likely that
the sociocultural behavior rather than neurobiological
factors influence the circadian pattern of sleep. Rein-
forcement of proper behavior and sleep hygiene should be
encouraged to help control of seizure in JME.
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